Muscle Wasting Disorders Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What are the Key Projections for the CAGR of the Muscle Wasting Disorders Market From 2025 to 2034?
The market size for muscle wasting disorders has experienced rapid expansion recently. The progression is expected to rise from a value of $15.06 billion in 2024 up to $17.54 billion in 2025, with a compound annual growth rate (CAGR) of 16.5%. This historic growth is linked to factors such as the growing elderly population, a surge in chronic diseases, advancements in R&D, heightened awareness for early diagnosis, and the rise of new therapeutic methods.
The market for muscle wasting disorders is projected to witness a fast-paced expansion in the coming years, escalating to a value of $29.67 billion in 2029, reflecting a compound annual growth rate (CAGR) of 14.1%. Factors contributing to this growth in the projected period include regulatory backing, patient support initiatives, improvements in healthcare infrastructure, global standardization of clinical trials, and personalized medicine approaches. Key trends observed during this forecast period incorporate the adoption of telemedicine, advancements in diagnostic technology, product innovations, strategic collaborations and partnerships, developments in therapeutics, molecular mechanism research, and innovative biopharmaceutical practices.
What Drivers Are Shaping the Growth of the Muscle Wasting Disorders Market?
The increasing trend of living a sedentary lifestyle is predicted to stimulate the expansion of the muscle wasting disorders market. A sedentary lifestyle is characterized by a person being physically inactive, with minimal or no engagement in physical exercise. This inactive behavior can detrimentally affect muscle functionality, leading to a decrease in muscle strength and stamina, fostering muscle wasting disorders, and making it challenging for people to preserve their muscle mass and function. For instance, in 2022, the World Health Organization, an intergovernmental organization based in Switzerland, reported that over 80% of adolescents and 27% of adults failed to meet the prescribed levels of physical activity. Consequently, the escalating trend of a sedentary lifestyle is fueling the expansion of the muscle wasting disorders market.
Get Your Free Sample of the Global Muscle Wasting Disorders Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp
What Are the Key Industry Players Leading the Charge in the Muscle Wasting Disorders Market’s Growth?
Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix, MyoKardia, Inc., MyoTherix Inc.
How Are Market Trends and Shifts Impacting the Growth Trajectory of the Muscle Wasting Disorders Market?
Leading firms in the muscle wasting disorders market are pioneering innovative products like new gene therapy approaches to provide superior care for muscle wasting disorder patients. This unique form of gene therapy pertains to a medical process that aspires to create a healing outcome by modifying gene expression or changing the biological attributes of live cells. As an example, Sarepta Therapeutics, a biotechnology firm based in the US, launched Elevidys in June 2023. This is the first-ever gene therapy to receive approval from the U.S. Food and Drug Administration (FDA) for treating Duchenne muscular dystrophy (DMD) in young patients aged between 4 and 5. Elevidys, a recombinant gene therapy, is designed to introduce into the human body a gene resulting in a shorter protein containing chosen domains of the dystrophin protein found in healthy muscle cells. The therapy is delivered through a single intravenous infusion.
Get Instant Access to the Global Muscle Wasting Disorders Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report
Which Segments Play a Crucial Role in the Expansion of the Muscle Wasting Disorders Market?
The muscle wasting disorders market covered in this report is segmented –
1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users
Subsegments:
1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents
2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs
3) By Nutritional Therapy: Protein Supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements
4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions
5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques
6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices
What Regions Are Influencing the Dynamics of the Muscle Wasting Disorders Market?
North America was the largest region in the muscle wasting disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Elements Shape the Definition of the Muscle Wasting Disorders Market?
Muscle wasting disorders, or muscle atrophy or muscle wasting, refer to a condition characterized by a diverse group of conditions that cause the progressive loss of muscle mass and strength. This can occur as a result of various factors, including disuse, aging, malnutrition, neurodegenerative diseases, and certain medical conditions.
Browse Through More Similar Reports By The Business Research Company:
Anorectal Disorders Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/anorectal-disorders-treatment-global-market-report
Generic Musculoskeletal Disorders Drugs Global Market Report 2024
Optic Nerve Disorders Treatment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
